A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation

被引:0
|
作者
Yoshifumi Sonobe
Jihad Aburas
Gopinath Krishnan
Andrew C. Fleming
Ghanashyam Ghadge
Priota Islam
Eleanor C. Warren
Yuanzheng Gu
Mark W. Kankel
André E. X. Brown
Evangelos Kiskinis
Tania F. Gendron
Fen-Biao Gao
Raymond P. Roos
Paschalis Kratsios
机构
[1] University of Chicago Medical Center,Department of Neurology
[2] University of Chicago Medical Center,The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior
[3] University of Chicago,Department of Neurobiology
[4] University of Chicago,Department of Neurology
[5] University of Massachusetts Medical School,The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine
[6] Northwestern University,Institute of Clinical Sciences
[7] MRC London Institute of Medical Sciences,Department of Neuroscience
[8] Imperial College London,undefined
[9] Neuromuscular & Movement Disorders,undefined
[10] Biogen,undefined
[11] Mayo Clinic,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A hexanucleotide repeat expansion GGGGCC in the non-coding region of C9orf72 is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxic dipeptide repeats (DPRs) are synthesized from GGGGCC via repeat-associated non-AUG (RAN) translation. Here, we develop C. elegans models that express, either ubiquitously or exclusively in neurons, 75 GGGGCC repeats flanked by intronic C9orf72 sequence. The worms generate DPRs (poly-glycine-alanine [poly-GA], poly-glycine-proline [poly-GP]) and poly-glycine-arginine [poly-GR]), display neurodegeneration, and exhibit locomotor and lifespan defects. Mutation of a non-canonical translation-initiating codon (CUG) upstream of the repeats selectively reduces poly-GA steady-state levels and ameliorates disease, suggesting poly-GA is pathogenic. Importantly, loss-of-function mutations in the eukaryotic translation initiation factor 2D (eif-2D/eIF2D) reduce poly-GA and poly-GP levels, and increase lifespan in both C. elegans models. Our in vitro studies in mammalian cells yield similar results. Here, we show a conserved role for eif-2D/eIF2D in DPR expression.
引用
收藏
相关论文
共 50 条
  • [31] eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS
    Goodman, Lindsey D.
    Prudencio, Mercedes
    Srinivasan, Ananth R.
    Rifai, Olivia M.
    Lee, Virginia M. -Y.
    Petrucelli, Leonard
    Bonini, Nancy M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (1) : 62
  • [32] eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS
    Lindsey D. Goodman
    Mercedes Prudencio
    Ananth R. Srinivasan
    Olivia M. Rifai
    Virginia M.-Y. Lee
    Leonard Petrucelli
    Nancy M. Bonini
    Acta Neuropathologica Communications, 7
  • [33] AAV-Based Anti-RAN Antibody Therapy for C9orf72 ALS FTD
    Romano, Lisa E. L.
    Preston, Camille
    Ortiz, Tala
    Ajeridini, Ramadan
    Golliher, Hannah
    Carrell, Ellie
    Keiser, Megan
    Ames, Elaine
    Davidson, Beverly L.
    Ranum, Laura P. W.
    MOLECULAR THERAPY, 2024, 32 (04) : 146 - 147
  • [34] Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans
    Rudich, Paige
    Snoznik, Carley
    Watkins, Simon C.
    Monaghan, John
    Pandey, Udai Bhan
    Lamitina, S. Todd
    HUMAN MOLECULAR GENETICS, 2017, 26 (24) : 4916 - 4928
  • [35] Phenotype of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia with ALS (FTD/ALS) Associated with the GGGGCC Repeat Expansion in C9ORF72 (c9FTD/ALS)
    Boylan, Kevin
    DeJesus-Hernandez, Mariely
    Rush, Beth
    Desaro, Pamela
    Johnston, Amelia
    Kryston, Thomas
    Rutherford, Nicola
    Baker, Matt
    Wszolek, Zbigniew
    Dickson, Dennis
    Rademakers, Rosa
    NEUROLOGY, 2012, 78
  • [36] A deletion mutant in the C. elegans orthologue of C9orf72 provides an animal model for studies on FTLD/ALS
    Partridge, F. A.
    Pickering-Brown, S.
    Sattelle, D. B.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 41 - 41
  • [37] In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study
    Mueller, Hans-Peter
    Del Tredici, Kelly
    Lule, Dorothee
    Mueller, Kathrin
    Weishaupt, Jochen H.
    Ludolph, Albert C.
    Kassubek, Jan
    NEUROIMAGE-CLINICAL, 2020, 27
  • [38] TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS
    Lee, Samuel
    Asress, Seneshaw
    Hales, Chadwick
    Vizcarra, Juan
    Gutman, David
    Gearing, Marla
    Chin, Lih-Shen
    Li, Lian
    Glass, Jonathan
    NEUROLOGY, 2019, 92 (15)
  • [39] Phenotype of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia with ALS (FTD/ALS) Associated with the GGGGCC Repeat Expansion in C9ORF72 (c9FTD/ALS)
    Boylan, Kevin
    DeJesus-Hernandez, Mariely
    Rush, Beth
    Desaro, Pamela
    Johnston, Amelia
    Kryston, Thomas
    Rutherford, Nicola
    Baker, Matt
    Wszolek, Zbigniew
    Dickson, Dennis
    Rademakers, Rosa
    NEUROLOGY, 2012, 78
  • [40] A deletion mutant in the C. elegans orthologue of C9orf72 provides an animal model for studies on FTLD/ALS
    Partridge, F. A.
    Pickering-Brown, S.
    Sattelle, D. B.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 286 - 287